Daly City, CA, United States of America

Tien Thuy Nguyen

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Tien Thuy Nguyen: Innovator in Ophthalmic Drug Compositions

Introduction

Tien Thuy Nguyen is a prominent inventor based in Daly City, California. She has made significant contributions to the field of ophthalmology through her innovative drug compositions. With a total of six patents to her name, Nguyen's work focuses on improving treatment methods for ocular diseases.

Latest Patents

Nguyen's latest patents include groundbreaking formulations for ophthalmic drug compositions. One of her inventions provides a drug composition that comprises particles made from a biodegradable or bioerodable polymer, along with a drug, a soluble excipient, a bulking agent, and a reconstitution aid. This invention also details a pharmaceutical formulation and a unit dosage form, along with methods for treating various diseases or conditions. Another notable patent involves sterile lyophilized drug compositions aimed at treating ocular diseases, utilizing similar components to enhance efficacy and safety.

Career Highlights

Throughout her career, Nguyen has worked with notable companies such as Med Alliance SA and Oxular Limited. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in ophthalmic treatments.

Collaborations

Nguyen has collaborated with esteemed colleagues, including Ronald Kenichi Yamamoto and Michael Thomas Ahlering. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field.

Conclusion

Tien Thuy Nguyen's contributions to ophthalmic drug compositions highlight her innovative spirit and dedication to improving healthcare. Her patents reflect a commitment to advancing treatment options for ocular diseases, making her a significant figure in the field of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…